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Production of hemopexin by TNF- stimulated human mes- phase reactants produced by hepatocytes [3, 4]. How-
angial cells. ever, recently, other sites of hemopexin production have
Background. Plasma hemopexin has been shown to induce been detected (i.e., mononuclear blood cells [5], retinaproteinuria after intrarenal infusion in rats, as well as glomeru-
cells, and in neural tissue [6–10]). It has also been re-lar alterations identical to those seen in corticosteroid-respon-
sive nephrotic syndrome (CRNS). The question emerged whe- cently shown from studies with hemopexin-deficient
ther also renal cells are potentially able to release hemopexin. mice that the most significant role of hemopexin is that
Methods. Normal human mesangial cells (HMC) were incu- of protecting cells against heme toxicity rather than par-bated overnight in serum-free medium with or without tumor
ticipating in iron metabolism [11].necrosis factor- (TNF-) (10 ng/mL). Parallel cultures were
supplemented with prednisolone (103 mol/L). Concentrated Previously, we proposed that hemopexin may act as
supernatants were analyzed by Western blotting, using anti- a potential proteinuria-promoting factor associated with
hemopexin immunoglobulin G (IgG). Antitransferrin IgG corticosteroid-responsive nephrotic syndrome (CRNS)served as control antibody. In addition, cytospins were stained
[12]. This association was based upon the observationusing polyclonal or monoclonal antihemopexin IgG. A part of
that CRNS-like glomerular lesions as well as proteinuriathe cells was used for RNA isolation and reverse transcription-
polymerase chain reaction (RT-PCR), to study hemopexin could be induced after intrarenal infusion of hemopexin
mRNA. into the rat [13]. Identical effects are seen following in-
Results. Eighty five kD bands were exclusively detected by
fusion of recombinant human hemopexin into rats (toantihemopexin IgG in the Western blots in supernatants from
be reported). In addition, following contact with renalTNF-–stimulated cultures and to a lesser extent in pred-
nisolone-treated cultures. Cells from TNF-–stimulated cul- tissue in vitro, this active isoform of hemopexin is able
tures stain positive for hemopexin in contrast to those from to induce identical glomerular alterations (i.e., loss of
prednisolone-treated or nonstimulated cultures. RT-PCR data
anionic sites and loss of glomerular ecto apyrase expres-suggest that mRNA for hemopexin is up-regulated in TNF-–
sion), whereas this activity could be inhibited by serinetreated versus prednisolone-treated HMC.
Conclusion. Stimulated HMC are able to release hemopexin protease inhibitors but not by collagenase inhibitors [12].
in vitro in a corticosteroid-dependent manner. As preliminary In patients with CRNS in relapse versus remission, the
data indicate that mesangial hemopexin is able to affect glomer- plasma hemopexin level is decreased, whereas urinary ex-ular anionic sites, it is conceivable that stimulated mesangium
cretion of this protein could be excluded, suggesting thatmay contribute to enhanced glomerular permeability in CRNS
through local hemopexin release. increased turnover of hemopexin may have occurred
in these subjects [14] (abstract; Cheung PK, J Am Soc
Nephrol 9:85A, 1998).
Hemopexin is an acute phase reactant present in the As it has been shown in experimental animals that
mammalian and human circulation [1, 2]. Hemopexin, hemopexin can be produced locally by various cells out-
which is known as a scavenger of heme, is like other acute side the liver after proinflammatory stimulation [5], the
question arises whether besides circulating hemopexin,
intraglomerular-generated hemopexin might also be pro-Key words: hemopexin, mesangium, corticosteroid responsive nephrotic
syndrome, TNF-, inflammation, prednisolone. duced by human mesangial cells.
In the present communication, we show that human
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pears that mesangial hemopexin production in vitro could BRL, Eggenstein, Germany) supplemented with 10%
heat inactivated fetal calf serum (FCS), 100 U/mL peni-be inhibited by treatment of the cells with prednisolone.
cillin, 100g/mL streptomycin, and 2 mmol/L glutamine.
Subcultures were performed using trypsin/ethylenedi-
METHODS
aminetetraacetic acid (EDTA) and cells were plated in
Experimental design 75 cm2 flasks (Costar, Corning, NY, USA). Confluent
cultures were washed with culture medium and incu-Confluent mesangial cell cultures were washed with
RPMI 1640 medium and incubated in serum-free me- bated overnight in serum-free medium supplemented
with either TNF- (10.0 ng/mL), a combination of TNF-dium overnight with or without TNF- (10 ng/mL).
Parallel cultures were supplemented with prednisolone (10.0 ng/mL) and prednisolone (103 mol/L) or predniso-
lone alone (103 mol/L).(103 mol/L). Culture supernatants were subsequently
harvested, concentrated, and examined for the presence Subsequently cultures were carefully removed from
the bottom of the culture flasks, counted (microcell-of hemopexin by sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) and Western blot ana- counter F800 Sysmex) and cytospins were prepared ac-
cording to standard procedures. Cell viability, as mea-lysis using rabbit antihemopexin immunoglobulin G
(IgG). Antihuman transferrin IgG served as control anti- sured by dye exclusion, was approximately 97%. A part
of the cells were frozen at 80C and used for RNA iso-body to check for nonspecific staining.
Cells were carefully detached from the culture flasks lation. Supernatants were harvested and concentrated
using Amicon B15 blocks (Millipore Corporation, Bed-using a cell scraper, washed, and cytospins were pre-
pared, fixed with acetone and stained for hemopexin ford, MA, USA).
using monoclonal or polyclonal antihemopexin IgG, or
Immunostaining of mesangial cellsantitransferrin as a control antibody.
A part of the cells of the primary cell cultures was Cytospin preparations were fixed with ice-cold acetone
(100%; 20C) for 10 minutes, air dried and subse-used for mRNA isolation and reverse transcription-poly-
merase chain reaction (RT-PCR) to study the mRNA quently stained for hemopexin, using either rabbit anti-
hemopexin IgG (Dako A/S, Glostrup, Denmark) andsignal for hemopexin.
goat antirabbit IgG conjugated with peroxidase (Garpo;
Culture of human mesangial cells Dako) as a second step, or monoclonal antihemopexin
IgG, and peroxidase-conjugated rabbit antimouse IgGHuman mesangial cells were obtained from normal
kidney cortexes of patients undergoing unilateral ne- (Rampo; Dako), as a second step, followed by Garpo as
a third step. (Antihemopexin monoclonal antibody wasphrectomy for renal cell carcinoma. Only parts of the
cortex with normal glomerular morphology, as evaluated a gift from Dr E. Hansen, the University of Texas South-
western Medical Center at Dallas). The reaction productby routine staining with hematoxilin and eosin (H&E)
or periodic acid-Schiff (PAS) and histochemical staining was visualized using 3-amino-9-ethyl-carbazole accord-
ing to standard methods [17]. Cells stained for transferrinfor sialoglycoproteins using colloidal iron [15], were
used. Isolation of mesangial cells was done as described using rabbit antihuman transferrin IgG (Behring, Mar-
burg, Germany) served as a control antibody. The sec-previously [16]. Briefly, glomeruli from the cortex of
human kidney tissue were isolated by a gradual sieving tions were counterstained using hematoxylin.
procedure. Glomeruli were plated out onto gelatin-
Analysis of culture supernatantscoated wells and then attached themselves within a few
days. Outgrowth of predominantly epithelial cells and a Culture supernatants were dialysed against PBS pH 8.0
and run over gradient PAGE (4% to 15%; BioRad Labo-limited number of endothelial cells were noted. Within
10 to 30 days after the glomeruli were seeded, outgrowth ratories, Hercules, CA, USA) and the proteins were
visualized with Ponceau-S (Pharmacia, Uppsala, Swe-of mesangial was observed. Mesangial cells were selec-
tively collected by scraping them from the tissue culture den), together with prestained marker molecules (Bio-
Rad Laboratories) according to standard methods. West-plate using a disposable cell scraper and subsequently
expanded on gelatin-coated wells. To purify the mesan- ern blots were prepared and stained with either rabbit
antihemopexin IgG, or control antibodies (antitrans-gial cell populations further, an immunomagnetic separa-
tion technique was used. The cultured mesangial cells ferrin IgG), Garpo, and peroxidase-conjugated rabbit
antigoat IgG (Ragpo; Dako) as a second and third step,showed no immunoreactivity to antiplatelet-endothelial
cell adhesion molecule-1 (PECAM-1) antibody or the respectively. To evaluate the specificity of antihemo-
pexin monoclonal antibody, this antibody was used toanticytokeratin-8 antibody, excluding the presence of
endothelial or epithelial cells. Cultured human mesangial detect purified plasma hemopexin in the Western blot.
Matrix metalloproteinase-2 (MMP-2) and MMP-9 (Neo-cells were studied between passages 5 and 10.
Cells were cultured in RPMI 1640 medium (Gibco markers, Fremont, CA, USA; Sigma, Zwijndrecht, The
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Fig. 1. Photomicrographs of mesangial cells
following culture in serum-free conditions with-
out stimulation (A), after stimulation by tumor
necrosis factor- (TNF-) (B) or with TNF-
and prednisolone (C ). Cytospins preparations
were stained for hemopexin using rabbit anti-
hemopexin IgG and peroxidase-conjugated
goat antirabbit as a second step. Reaction prod-
uct throughout the cytoplasm is seen in most
stimulated cells (B, arrowhead); negative cells
are also present (arrow). Nonstimulated cells
stain predominantly negative (A), whereas stim-
ulated cells after prednisolone treatment show
also reduced stainability, although some mem-
brane staining can be observed in these cells
(C, arrow). Final magnification 300.
Fig. 2. Photomicrographs of cultured mesan-
gial cells stained for hemopexin expression
by monoclonal antihemopexin IgG antibody
using peroxidase-conjugated rabbit antimouse
and peroxidase-conjugated goat antirabbit IgG
as a second and third step, respectively. It can
be seen that, compared with unstimulated cells
(A), predominant hemopexin staining occurs
in mesangial cells after stimulation with tumor-
necrosis factor- (TNF-) (B). Final magnifi-
cation 300.
Netherlands) were used as control antigens. (These mol- 5-TACAGAGCTGAGTTTGTAGC-3) and only those
cases for which no PCR product was obtained were usedecules were selected as they are known to contain hemo-
pexin-like domains). for a further analysis.
The cDNA synthesis was primed with oligo(dT) using
Detection of hemopexin mRNA in primary the protocol provided by the manufacturer (Gibco BRL,
mesangium cells Eggenstein, Germany). Hemopexin primers were se-
lected from the sequence presented in the GenBankRNA was isolated from frozen mesangium cells. Total
RNA was isolated from either nonstimulated or TNF- (accession number M62642). Primer sequences used for
the amplification were hemopexin (f 5-GCACTCAGGstimulated cells with or without prednisolone treatment,
using Trizol (Life Technologies, Inc., Gaithersburg, MD, TATATGTCTTCC-3; r 5-GGGCTCCTGACTTCAG
GTCC-3) and the housekeeping gene glyceraldehydes-USA).
RNA isolation is followed by DNAse treatment ac- 3-phosphage dehydrogenase (GAPDH) (f 5-CCATC
ACTGCCACTCAGAAGACT-3, r 5-TTACTCCTTGcording to the protocol from the manufacturer (Mes-
sageClean Kit; Gen Hunter Corp., Nashville, TN, USA). GAGGCCATGTAGG-3). PCR for all primer sets was
performed with 1 unit of Taq-polymerase (PharmaciaThe quality of isolated total RNA was checked using
1% agarose gel. DNAse treatment was tested by PCR Biotech) and the reaction buffer provided by the manu-
facturer. The PCR program of hemopexin consisted ofusing a dinucleotide primer set D11S875 specific for ge-
nomic DNA (5-ACTGTCCTCTCATCCTACTG-3 and 30 cycles with a denaturation step of 30 seconds at 94C,
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Fig. 4. Gel electrophoresis of hemopexin (Hx). Reverse transcription-
polymerase chain reaction (RT-PCR) products from tumor necrosis
factor- (TNF-)–stimulated mesangial cells with or without predniso-
lone (upper panel). The lower panel shows RT-PCR products from glycer-
aldehydes-3-phosphate dehydrogenase (GAPDH) (housekeeping gene).
Clear down-regulation of hemopexin expression following TNF- stim-
ulation with prednisolone versus TNF- stimulation alone can be seen
in the upper panel.
Fig. 3. Western blot stained for hemopexin showing 85 kD bands. It
can be seen that an 85 kD band appears in supernatants of tumor in Figure 3 are not due to nonspecific binding of IgG to
necrosis factor- (TNF-)–stimulated cultures (lane 3). An identical hemopexin molecules (results not shown).band, although less prominent, can be seen in TNF-–stimulated cul-
In addition, RT-PCR revealed a reduced signal fortures after prednisolone treatment (lane 2), whereas no detectable 85
kD band can be seen in unstimulated cultures (lane 1). M is marker hemopexin in stimulated cells treated with prednisolone
molecules. as compared with TNF-–stimulated cells (Fig. 4).
The specificity of the monoclonal mouse anti hemo-
pexin IgG was confirmed by Western blotting showing
a single 80 kD band with purified plasma hemopexin,an annealing step of 40 seconds at 57C, and an extension
whereas control molecules (i.e., MMP-2 or MMP-9) stainstep of 40 seconds at 72C. The first denaturing step
negative (Fig. 5). Polyclonal antihemopexin IgG doeslasted 5 minutes and the final extension step lasted 7
not recognize MMP-2 or MMP-9 molcules in the West-minutes. Amplification of GAPDH was performed for
ern blot (results not shown).20 cycles and used as control to compare mRNA amounts.
DISCUSSION
RESULTS
The aim of the present study was to confirm and extend
The majority of cells stimulated with TNF- stained our preliminary observation of a novel activity of mesan-
positive for hemopexin using polyclonal antihemopexin gial cells in vitro (i.e., the production and release of
IgG (Fig. 1B). In contrast nonstimulated cells, and to a hemopexin). It is clear from Figures 1 and 2 that TNF-–
lesser extent stimulated cells treated with prednisolone, stimulated cells synthetize hemopexin. In addition, it
stained predominantly negative (Fig. 1 A and C), although appeared that this synthesis is inhibited by prednisolone.
in several cells some membrane staining could be seen Up-regulation of hemopexin by TNF- and inhibition
after prednisolone treatment (Fig. 1C). When the cells by corticosteroids in mesangial cell cultures is consistent
were stained for hemopexin using monoclonal antihemo- with the mRNA signals (Fig. 4), supporting the idea that
pexin IgG, again exclusively positive staining in TNF- increased hemopexin protein expression relates to he-
stimulated cells occurred (Fig. 2). Staining with antitrans- mopexin transcription and synthesis in these cells. The
ferrin IgG as a control antibody was negative (results finding that hemopexin is also detectable in culture su-
not shown). pernatants of TNF-–stimulated cells (and to a lesser
Inhibition of hemopexin synthesis by prednisolone is extent in those of prednisolone-treated cells) (Fig. 3) is
also reflected in the decreased release of this molecule in line with the immunostaining data and points to re-
in supernatants of stimulated cell culture treated with lease of hemopexin molecules by TNF-–stimulated
this drug. Supernatants of TNF- stimulated cultures mesangium cells.
showed a clear 85 kD band in the Western blot, whereas In view of decreased production of various molecules
a faint band was observed in supernatants from predniso- in other cell types due to corticosteroids [18–20], we feel
lone-treated cultures after stimulation with TNF- in vitro that the prednisolone effect observed in this particular
(Fig. 3). Western blots using antitransferrin antibody did cell in vitro is not surprising; however, some discrepancy
of the glucocorticoid action upon gene expression of acutenot show a 85 kD band indicating that the bands shown
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phase production exists. Thus, Baumann et al [21, 22]
observed enhancement of acute phase proteins, including
hemopexin in hepatocytes, after stimulation with con-
ditioned monocyte medium, while dexamethasone was
able to reduce the secretion of these proteins in vitro. On
the other hand, interleukin-6 (IL-6)–induced hemopexin
release in a rat hepatoma cell line was enhanced by
transforming growth factor- (TGF-), whereas dexa-
methasone was up-regulating this TGF-–dependent IL-6
response in vitro [23]. In addition, species differences
were shown regarding the effect of glucocorticoid upon
hemopexin production [24], whereas it has been shown
that corticosteroids can enhance or diminish gene ex-
pression of acute phase reactants depending on their
concentration [25]. In vivo, also, some discrepancy be-
tween glucocorticoid effects upon hemopexin production
was observed. Thus, Eastman et al [25] observed abolish-
ment of the hemopexin release after dexamethasone Fig. 5. Western blot stained for hemopexin (Hx). In a purified plasma
treatment of adrenalectomized rats, whereas Marinkovic hemopexin sample using monoclonal antihemopexin antibody, peroxi-
dase-conjugated rabbit antimouse IgG, and peroxidase-conjugated goatet al [26] described IL-6–induced hemopexin induction
antirabbit IgG as a second and third step, respectively, shows one bandin rats, which appeared to be enhanced by dexametha- of approximately 80 kD band (lane 3). Control molecules [i.e., matrix
sone in vivo. Be this as it may, our previous (unpublished) metalloproteinase (MMP-2) (lane 1) or MMP-9 (lane 2)] stain negative.
M is marker molecules.experiments with human mesangium cells stimulated with
IL-1 or IL-6 are in line with the present results showing
prednisolone-dependent hemopexin release.
Although the molecular weight of hemopexin may dif-
tissue and peritoneal macrophages by Camborieux et alfer in various hemopexin preparations due to different
[10]. These authors show up-regulation of hemopexinlevels of glycosylation [1, 2], we feel that the data so far are
production in peritoneal mononuclear cells followingconsistent with hemopexin being the molecule involved.
stimulation with proinflammatory agents such as lipo-This does not mean, however, that stimulated mesangial
polysaccharide or IL-6, as well as in regenerating neuralcells produce necessarily an identical isoform of hemo-
tissue. In addition it has been shown that hemopexin playspexin as compared with plasma hemopexin. The fact that
a key role in the homeostasis of nitric oxice radicals [31].our antihemopexin monoclonal antibody does not recog-
Since mesangium cells in particular are readily producingnize mesangial hemopexin in the Western blot (unpub-
nitric oxide in the inflammatory condition [32, 33], nitriclished results), in contrast to purified plasma hemopexin
oxide radical scavenging by mesangial hemopexin may(Fig. 5), may support this notion, although the possibility
reflect an important local protective principle within thethat this lack of recognition is due to the low amount of
glomerular microvasculature.mesangial antigen used in the blotting assay can not be
Whatever the relevance of locally produced hemo-excluded. Extended concentration and purification stud-
pexin may be in terms of heme scavenging, our previousies with mesangial culture supernatants are necessary to
observation that the protease-like activity of hemopexinsettle this issue. Preliminary experiments, however, indi-
can promote proteinuria [13] may be of interest for bettercate that purified mesangial hemopexin isolated from the
understanding of the pathophysiology of corticosteroid-supernatants of stimulated mesangial cells shows serine
responsive proteinuria. The present findings open theprotease activity, as is the case in plasma hemopexin [12].
possibility that in pathologic conditions this potentiallyThese data taken together, we feel that stimulated mes-
proteinuria-inducing molecule can be produced in theangial cells like monocytes and fibroblasts [10] are poten-
glomerulus itself following local activation by cytokinestially able to locally produce hemopexin. The relevance
in vivo.of this capability is unclear but may subserve a local
In view of the suggested relationship between cellularprotective function, through binding of free heme. Since
immune responses and the pathogenesis of CRNS [34–36],accumulating evidence suggest that free heme can act as
it is tempting to speculate that a T cell–mediated eventa proinflammatory signaling molecule, playing a role as
leading to relevance of proinflammatory cytokines maycatalyst in the oxidation of lipids, proteins, and DNA
trigger mesangial hemopexin release promoting enhanced[27–30], local production of heme-binding molecules may
glomerular permeability. Further studies, using mesan-protect the tissue from heme-mediated injury. Such a
local protection has been recently suggested for neural gial cells from biopsies of patients with CRNS in relapse
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